Advances in multi-omics study of biomarkers of glycolipid metabolism disorder.

Advances in multi-omics study of biomarkers of glycolipid metabolism disorder.
复制标题

糖脂代谢紊乱生物标志物多组学研究进展

DOI:
10.1016/j.csbj.2022.10.030
复制
发表时间:
2022
影响因子:
6
通讯作者:
Tian, Jiaxing
Tian, Jiaxing
中科院分区:
生物学2区
文献类型:
--
作者:
Fang, Xinyi;Miao, Runyu;Wei, Jiahua;Wu, Haoran;Tian, Jiaxing

文献摘要

参考文献

被引文献

相似文献

糖脂代谢紊乱是威胁人类健康和生命的重大问题。遗传、环境、心理、细胞和分子因素导致其发病。多项研究表明,神经内分泌轴功能障碍、胰岛素抵抗、氧化应激、慢性炎症反应和肠道菌群失调是与之相关的核心病理环节。然而,糖脂代谢紊乱的潜在分子机制和治疗靶点仍有待阐明。高通量技术的进步有助于阐明糖脂代谢紊乱的病理生理学。在本综述中,我们探讨了基因组学、转录组学、蛋白质组学、代谢组学和肠道微生物组学的方法和方法,可以帮助确定新的候选生物标志物,用于临床管理糖脂代谢紊乱。本文还讨论了多组学研究在这些疾病中的局限性和未来的研究方向。
Glycolipid metabolism disorder are major threats to human health and life. Genetic, environmental, psychological, cellular, and molecular factors contribute to their pathogenesis. Several studies demonstrated that neuroendocrine axis dysfunction, insulin resistance, oxidative stress, chronic inflammatory response, and gut microbiota dysbiosis are core pathological links associated with it. However, the underlying molecular mechanisms and therapeutic targets of glycolipid metabolism disorder remain to be elucidated. Progress in high-throughput technologies has helped clarify the pathophysiology of glycolipid metabolism disorder. In the present review, we explored the ways and means by which genomics, transcriptomics, proteomics, metabolomics, and gut microbiomics could help identify novel candidate biomarkers for the clinical management of glycolipid metabolism disorder. We also discuss the limitations and recommended future research directions of multi-omics studies on these diseases.
DOI: 10.2337/dci19-0066
发表时间: 2020-02-01
期刊: DIABETES CARE
影响因子: 16.2
作者:
Buse, John B.;Wexler, Deborah J.;Davies, Melanie J.
通讯作者: Davies, Melanie J.
DOI: 10.1371/journal.pone.0181880
发表时间: 2017
期刊: PloS one
影响因子: 3.7
作者:
Böhm A;Wagner R;Machicao F;Holst JJ;Gallwitz B;Stefan N;Fritsche A;Häring HU;Staiger H
通讯作者: Staiger H
脂肪组织转录组的从头重建揭示了棕色脂肪细胞发育的长无编码RNA调节剂。
DOI: 10.1016/j.cmet.2015.04.003
发表时间: 2015-05-05
期刊: Cell metabolism
影响因子: 29
作者:
Alvarez-Dominguez JR;Bai Z;Xu D;Yuan B;Lo KA;Yoon MJ;Lim YC;Knoll M;Slavov N;Chen S;Peng C;Lodish HF;Sun L
通讯作者: Sun L
DOI: 10.1007/s00125-018-4675-2
发表时间: 2018-09
期刊: Diabetologia
影响因子: 8.2
作者:
Eriksson JW;Lundkvist P;Jansson PA;Johansson L;Kvarnström M;Moris L;Miliotis T;Forsberg GB;Risérus U;Lind L;Oscarsson J
通讯作者: Oscarsson J
DOI: 10.1016/j.cmet.2013.12.015
发表时间: 2014-02-04
期刊: Cell metabolism
影响因子: 29
作者:
Balland E;Dam J;Langlet F;Caron E;Steculorum S;Messina A;Rasika S;Falluel-Morel A;Anouar Y;Dehouck B;Trinquet E;Jockers R;Bouret SG;Prévot V
通讯作者: Prévot V